ScholarIQanswers from OpenAlex

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer

PaperCitations, authors & open-access status

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer have?

ScholarIQcitation count

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer has 29 citations in the OpenAlex counts ScholarIQ stores.

When was TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer published?

ScholarIQyear

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer has 2022 year in the ScholarIQ index.

What is the open-access status of TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer?

ScholarIQoa status

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer has hybrid oa status in the ScholarIQ index.

What is the DOI of TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer?

ScholarIQdoi

The DOI for TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer is on the source record.

What is the PMID of TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer?

ScholarIQpmid

The PMID for TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer is on the source record.

What is the OpenAlex record for TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer?

ScholarIQopenalex

The OpenAlex for TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial